Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GENOSKIN logo — Redefining Non-Clinical Research with Live Human Skin

GENOSKIN

Redefining Non-Clinical Research with Live Human Skin

Founded 2011 United States Salem, United States 44 employees Series Unknown Total: $8.70M Biopharma, Biotechnology +2

General Information

Company Name GENOSKIN
Founded Year 2011
Location United States Salem, United States +2
Employees 44
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when GENOSKIN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GENOSKIN

GENOSKIN is a groundbreaking startup in the biopharma, biotechnology, health care, and pharmaceutical industries, founded in 2011. The company's slogan, "First-in-human data to accelerate drug development," reflects its mission to revolutionize the early phase development of biotherapeutics, vaccines, medical devices, and cosmetics. GENOSKIN sources ethically-derived human skin from plastic surgeries, offering a more ethical and reliable alternative to animal experimentation. Utilizing advanced technologies and customizable ex-vivo human skin models, GENOSKIN provides precise insights into substance interactions, predicting absorption and irritation effects. Recent advancements in transcriptomic analysis and spatial biology capabilities have enabled the comprehensive understanding of substance effects at molecular and cellular levels. As a United States-based startup, GENOSKIN has the potential to have a significant impact on biomedical research and product development across various industries. As of now, specific information about the latest investment and investors is not available, but given the innovative nature of the company and the pressing need for ethical and effective alternatives in research and development, GENOSKIN presents an intriguing opportunity for potential future investors.

Taxonomy: Drug development, First-in-human data, Human skin models, Pharmaceuticals, Cosmetics, Immunocompetent models, Topical administration, Systemic administration, Subcutaneous injections, Skin reactions, Immune response, Regulatory compliance, Ethical regulations, Quality control

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series Unknown •••••• 8
Investor Investor Investor Investor
•••• •••• 		16 Sep 2025

Latest News

View All
Genoskin raises $8.7M to advance human skin models as animal testing alternative — Tech
Genoskin raises $8.7M to advance human skin models as animal testing alternative
Tech Sep 16, 2025

GENOSKIN Alternatives & Competitors

GENOSKIN vs
Dermalogica
Dermalogica United States

Professional grade skincare education, products, and services to skin therapists and consumers alike...

1899 employees
Health and Wellness
Compare GENOSKIN vs Dermalogica
GENOSKIN vs
REVIVO BioSystems
REVIVO BioSystems Singapore

EXPERTS IN 4D TISSUE MODELS

11 employees
Biotechnology, Life Sciences
Compare GENOSKIN vs REVIVO BioSystems
GENOSKIN vs
Haut.AI
Haut.AI Estonia

Industry-leading AI company specialising in skincare and longevity, offering hyper-personalized tool...

Seed
51 employees
AI, E-Commerce
Compare GENOSKIN vs Haut.AI

FAQ About GENOSKIN

Redefining Non-Clinical Research with Live Human Skin
GENOSKIN was founded in 2011.
GENOSKIN is headquartered in Salem, United States.
GENOSKIN operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
GENOSKIN has approximately 44 employees.
GENOSKIN has completed 1 funding round, raising a total of $8.70M. The latest funding stage is Series Unknown.
Top alternatives and competitors to GENOSKIN include Dermalogica, REVIVO BioSystems, Haut.AI, DERMALA Inc., ZO Skin Health, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GENOSKIN and Dermalogica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GENOSKIN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy